Our results are concordant with the outcome of SMC1A knocking down in both glioma and lung adenocarcinoma cells, in which cell proliferation was suppressed through G1/S or G2/M phase cell cycle arrest [45, 46]. The gene discussed is SMC1A; the disease is central nervous system cancer.